Vaccines, blood, antisera, toxins and cultures in   Israel

Exports In 2022, Israel exported $304M in Vaccines, blood, antisera, toxins and cultures, making it the 31st largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 49th most exported product in Israel. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Israel are: United States ($71.8M), Austria ($47.2M), Belgium ($42.4M), Germany ($24.1M), and Palestine ($13.3M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Israel between 2021 and 2022 were Austria ($17.1M), Poland ($2.63M), and Brazil ($1.06M).

Imports In 2022, Israel imported $1.39B in Vaccines, blood, antisera, toxins and cultures, becoming the 30th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 9th most imported product in Israel. Israel imports Vaccines, blood, antisera, toxins and cultures primarily from: Switzerland ($301M), Belgium ($284M), Netherlands ($198M), Germany ($164M), and United States ($88.2M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Israel between 2021 and 2022 were Poland ($26.6M), Austria ($24.2M), and Lithuania ($20.3M).